A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.

<h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies...

Full description

Bibliographic Details
Main Authors: Sahar Radwan, Darby Gilfillan, Bridget Eklund, Hend M Radwan, Nagwan G El Menofy, Justin Lee, Marylee Kapuscinski, Zaid Abdo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0238764
id doaj-dbc21199978a44ee93cdd6748686691a
record_format Article
spelling doaj-dbc21199978a44ee93cdd6748686691a2021-03-04T11:13:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01159e023876410.1371/journal.pone.0238764A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.Sahar RadwanDarby GilfillanBridget EklundHend M RadwanNagwan G El MenofyJustin LeeMarylee KapuscinskiZaid Abdo<h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies have proposed that disturbance of gut microbiota could influence TIID development and indicated associations between a reduced diversity in microbiomes and Type I diabetes (TID). In the present study, we investigated the composition and abundance of the bacterial microbiome in disease state (TID and TIID) of Egyptian patients. Our goal in this study was to characterize features of the gut microbiota and possible differences associated with TID and TIID in this population.<h4>Methods</h4>DNA was extracted from fecal samples taken from 22 TID and 18 TIID outpatients of Al-Hussein hospital, Cairo, Egypt. 16S rRNA amplicon sequencing was used to characterize the bacterial taxa and these reads were processed using the software mothur with analysis utilizing packages vegan, phyloseq and metagenomSeq in R.<h4>Results and conclusions</h4>Our results highlighted a significant increase in abundance of Gram negative, potentially opportunistic pathogenic taxa (Pseudomonas, Prevotella) in all diabetic groups, compared to the control. Lipopolysccharide (LPS), a component of the gram-negative bacterial wall, can activate local immune response and may result in low-grade systemic inflammation contributing to insulin resistance. The gram-positive Gemella, which is associated with increased risk to diabetes, also had a significant increase in abundance in all diabetic groups, compared to the control. In contrast, the commensal bacterial taxa Turicibacter, Terrisporobacter and Clostridium were found to be more abundant in the control group than in TID. Further studies are needed to understand the role of these taxa in health and disease. Lower Richness and low Shannon diversity, though not statistically significant, were observed for TID subjects with no glucose control and with onset of liver disease or hypertension compared to other subjects. In addition, large variation in alpha diversity within the control group could also be observed. Future studies will include larger samples sizes to further elucidate these findings, as well as possible metagenomic studies to examine the intriguing function of significant microbes.https://doi.org/10.1371/journal.pone.0238764
collection DOAJ
language English
format Article
sources DOAJ
author Sahar Radwan
Darby Gilfillan
Bridget Eklund
Hend M Radwan
Nagwan G El Menofy
Justin Lee
Marylee Kapuscinski
Zaid Abdo
spellingShingle Sahar Radwan
Darby Gilfillan
Bridget Eklund
Hend M Radwan
Nagwan G El Menofy
Justin Lee
Marylee Kapuscinski
Zaid Abdo
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
PLoS ONE
author_facet Sahar Radwan
Darby Gilfillan
Bridget Eklund
Hend M Radwan
Nagwan G El Menofy
Justin Lee
Marylee Kapuscinski
Zaid Abdo
author_sort Sahar Radwan
title A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
title_short A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
title_full A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
title_fullStr A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
title_full_unstemmed A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
title_sort comparative study of the gut microbiome in egyptian patients with type i and type ii diabetes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description <h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies have proposed that disturbance of gut microbiota could influence TIID development and indicated associations between a reduced diversity in microbiomes and Type I diabetes (TID). In the present study, we investigated the composition and abundance of the bacterial microbiome in disease state (TID and TIID) of Egyptian patients. Our goal in this study was to characterize features of the gut microbiota and possible differences associated with TID and TIID in this population.<h4>Methods</h4>DNA was extracted from fecal samples taken from 22 TID and 18 TIID outpatients of Al-Hussein hospital, Cairo, Egypt. 16S rRNA amplicon sequencing was used to characterize the bacterial taxa and these reads were processed using the software mothur with analysis utilizing packages vegan, phyloseq and metagenomSeq in R.<h4>Results and conclusions</h4>Our results highlighted a significant increase in abundance of Gram negative, potentially opportunistic pathogenic taxa (Pseudomonas, Prevotella) in all diabetic groups, compared to the control. Lipopolysccharide (LPS), a component of the gram-negative bacterial wall, can activate local immune response and may result in low-grade systemic inflammation contributing to insulin resistance. The gram-positive Gemella, which is associated with increased risk to diabetes, also had a significant increase in abundance in all diabetic groups, compared to the control. In contrast, the commensal bacterial taxa Turicibacter, Terrisporobacter and Clostridium were found to be more abundant in the control group than in TID. Further studies are needed to understand the role of these taxa in health and disease. Lower Richness and low Shannon diversity, though not statistically significant, were observed for TID subjects with no glucose control and with onset of liver disease or hypertension compared to other subjects. In addition, large variation in alpha diversity within the control group could also be observed. Future studies will include larger samples sizes to further elucidate these findings, as well as possible metagenomic studies to examine the intriguing function of significant microbes.
url https://doi.org/10.1371/journal.pone.0238764
work_keys_str_mv AT saharradwan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT darbygilfillan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT bridgeteklund acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT hendmradwan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT nagwangelmenofy acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT justinlee acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT maryleekapuscinski acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT zaidabdo acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT saharradwan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT darbygilfillan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT bridgeteklund comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT hendmradwan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT nagwangelmenofy comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT justinlee comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT maryleekapuscinski comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
AT zaidabdo comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes
_version_ 1714804451346219008